CHEK2 and neoplasm: The diagrams in Figure 5 demonstrate that under the influence of compounds 12a and 13d in Jurkat tumor cells, the content of phosphorylated checkpoint kinases Chk1 and Chk2 significantly decreases, as when treating with staurosporine, valinomycin, rapamycin and CCCP.